Investors News / RNS

Date	Links
27 November 2008	Final Results for the year ended 30 June 2008
17 November 2008	Physiomics presentation at Bio-Europe Conference
20 August 2008	Physiomics to present on Chronotherapy at the International Conference on Systems Biology
28 July 2008	Trading Statement
14 July 2008	Physiomics Technology in continued and expanded support of Lilly's Oncology Programs
20 June 2008	Holdings in Company
03 June 2008	Beyond Genome Presentation
20 May 2008	Tempo Project Update
22 Apr 2008	Holdings in Company
08 Apr 2008	AACR Presentation Update
31 Mar 2008	Interim Results
15 Feb 2008	Related party loan
14 Feb 2008	Management Appointment
13 Feb 2008	Physiomics AACR Presentation
20 Dec 2007	Board changes
17 Dec 2007	MOU with Swansea University (access to Supercomputer “Blue C”)
12 Dec 2007	Physiomics Collaboration Update – Cancer Cell Death Model Developed
30 Nov 2007	Holdings in Company
28 Nov 2007	Notice of Annual General Meeting and Final Results
24 Sep 2007	Holdings in Company
17 Sep 2007	Holdings in Company
17 Sep 2007	Holdings in Company
17 Sep 2007	Physiomics Technology in support of Eli Lilly Oncology Program
16 Aug 2007	AIM Rule 26 information
13 Aug 2007	Holdings in Company
07 Aug 2007	Holdings in Company
18 May 2007	Appointment of Christophe Chassagnole as Chief Operating Officer
07 Mar 2007	Interim Results
15 Feb 2007	Agreement announced between ValiRx plc and Physiomics plc
02 Jan 2007	Result of Annual General Meeting
19 Dec 2006	Total Voting Rights
07 Dec 2006	Notice of AGM and prelims
28 Nov 2006	Physiomics plc Announces its Participation in the European TEMPO Project
7 Nov 2006	Holding(s) in Company
29 Sep 2006	Additional Listings
28 Sep 2006	EGM Statement
5 Sep 2006	Notice of Extraordinary General Meeting ('EGM')
1 Sep 2006	Board changes, Placing, Appointment of broker
8 Jun 2006	Board changes
31 Mar 2006	Interim Results
22 Dec 2005	Physiomics Annual General Meeting 2005
25 Oct 2005	Major Technical Advance
18 Oct 2005	Acquisition of shares by CEO
28 Sep 2005	Preliminary results for the period ended 30 June 2005
26 Aug 2005	Appointment of David Evans as non-Executive Chairman
23 Jun 2005	Physiomics and Bayer launch a new Service
21 Mar 2005	Interim Results for 6 months to 31st December 2004
24 Dec 2004	UK Patent Registered to Physiomics
20 Dec 2004	First Day of Trading on AIM
23 Nov 2004	Physiomics and Cronos Therapeutics to develop GeneICE for cancer
14 Sep 2004	Bayer Technology Services and Physiomics sign collaboration
Mar 2003	SMART Award

This part of the website has been designed to comply with the requirements of Rule 26 of the AIM Rules for Companies - 'Company information disclosure'

Document Last Updated Monday, 28 July 2008